the international arm is the patients embolized with drug eluting bead trans arterial chemo embolization using Hepasphere

the control arm is the patients embolized with drug eluting bead trans arterial chemo embolization using Lipiodol

Hepatic Cell Carcinoma

evaluation the tumor (size, location and pattern of enhancement) ;and ensure portal vein patency; then evaluation of hepatic arterial anatomy, after that we determine the tumor arterial feeders and the arteries that should be avoided during the maneuver.
Selective celiac and superior mesenteric angiograms were performed using 5 Fr. Catheter then superselective angiogram were used microcatheter. then injection of drug-eluting microsphere (25 mg Hepasphere 50-100 micron) loaded with 50 mg doxorubicin solution for 2 hours.

HepaSphere Microspheres/Doxorubicin Hydrochloride

evaluation the tumor (size, location and pattern of enhancement) ;and ensure portal vein patency; then evaluation of hepatic arterial anatomy, after that we determine the tumor arterial feeders and the arteries that should be avoided during the maneuver.
Selective celiac and superior mesenteric angiograms were performed using 5 Fr. Catheter then superselective angiogram were used microcatheter. then injection of prepared mixture of Lipiodol and (Doxorubicin or 5-FU) vary in dosage depend on operator consideration

Lipiodol

Hepatic Arterial Infusion of Doxorubicin-Loaded Microsphere for Treatment of Hepatocellular Cancer: A Multi-Institutional Registry

Effectiveness of Drug Eluting TACE in Primary HCC

Effectiveness of Drug Eluting & Conventional Trans-arterial Chemo-embolization in Treatment of Primary Hepatic Cell Carcinoma

Evaluate the efficacy and safety of drug-eluting bead trans-arterial chemo-embolization in management of HCC patients in comparison of conventional chemo-embolization in 75 stable patients by evaluating the response of embolized lesions for each drug with modified RECIST criteria.

Ahmed Mohammed Hassan Taha Abdurabou

Resident radiologist

Assiut University

One hundred five patients were randomized to receive intravenous dexamethasone (8 mg) before laparoscopic cholecystectomy

One hundred five patients were randomized to receive intravenous placebo before laparoscopic cholecystectomy

Postoperative Nausea and Vomiting

Postoperative Pain

Postoperative Fatigue

intravenous dexamethasone 8 mgr before laparoscopic cholecystectomy or intravenous placebo before laparoscopic cholecystectomy

cholecystitis/fatigue

Effectiveness of Drug Eluting TACE in Primary HCC

Dexamethasone Improves Postoperative Symptoms After Laparoscopic Cholecystectomy

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu